CONNECT WITH US
HealthTech

HealthTech

Cholesterol control gets personalized—how new guidelines tailor treatment to your unique risk profile

Medical Xpress logo

Published on

Add as a preferred source on Google
Cholesterol control gets personalized—how new guidelines tailor treatment to your unique risk profile

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

At least a quarter of Americans have high levels of cholesterol or fatty acids in their blood, a condition called dyslipidemia. Uncontrolled cholesterol levels increase the risk of atherosclerotic cardiovascular disease, or ASCVD, a group of diseases that result from plaque buildup in blood vessels and prevent blood from flowing smoothly to vital organs. This can lead to a heart attack or stroke.

As a cardiologist with expertise in sports and exercise science, I routinely care for patients who want to make healthy lifestyle choices to control their cholesterol levels, reduce their risk of cardiovascular disease and improve their overall health.

In March 2026, the American Heart Association and the American College of Cardiology issued new guidelines on how to treat dyslipidemia. The guidelines, last updated in 2018, incorporate findings from several new studies on how to more effectively treat—and prevent—the condition.

The new guidelines can help doctors personalize treatment to reduce each patient's risk of developing cardiovascular disease.

Compared with prior guidelines, the 2026 update emphasizes treating high cholesterol and fatty acids earlier in life and more aggressively to reduce the risk of developing atherosclerotic cardiovascular disease later in life.

This push is based on the observation that the longer cholesterol levels remain high, the greater the lifetime risk of cardiovascular disease.

The new guidelines explain how clinicians can use blood tests and imaging tools to assess a person's risk of developing cardiovascular disease.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.